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Abstract We present a case of hypertrophic osteoar-
thropathy (PHO), with painful synovium hyperplasia
involving both knees that was refractory to corticosteroid
treatment. His rheumatoid factor and anti-CCP antibody
was negative, and his serum ESR and CRP level was within
normal range. Histological examination of the synovium
obtained from his right knee revealed endothelial hyper-
plasia and vascular thickening without inflammation that
was in association with aberrant expression of CD200/
CD200R1, which highlighted the importance of aberrant
CD200/CD200R1 in the regulation of the endothelial
activation that contributed to the development of synovium
hyperplasia in this PHO patient.
Keywords Primary hypertrophic osteoarthropathy 
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Introduction
Hypertrophic osteoarthropathy (PHO) is a rare disease of
unknown aetiology characterized by hypertrophic skin
changes, clubbing fingers and periostitis [1]. Synovial
effusion is less common usually symptomless. If painful, it
usually responds well to non-steroidal anti-inflammatory
drugs (NSAIDs). Here, we present a case of a PHO patient
with severe pain and swelling of both knees which were
refractory to NSAIDs and corticosteroid treatment. Histo-
logical examination of the synovium obtained from his
knee demonstrated endothelial hyperplasia and vascular
thickening without inflammation together with aberrant
CD200/CD200R1 expression.
Case report
This is a 28-year-old Chinese man with intermittent
arthralgia affecting multiple joints after strenuous work for
10 years. He complained of increasing disabling pain and
swelling of both knees in recent 6 months. He also had
profuse sweating of his palms and soles. He started NSA-
IDs 5 years ago with little symptom effect. His symptoms
did not respond to 30 mg/day of prednisone either. In
recent 3 months, he had a weight loss of around 5 kg and
developed hyperhidrosis. Physical examination revealed
pachydermia with a thickening of his forehead folds. He
had palmoplantar hyperhidrosis and cutis verticis gyrata,
severe clubbing of all his fingers and symmetrical effusion
in his knees and ankles (Fig. 1). Examination of his chest
and abdomen was unremarkable. His laboratory tests were
as follows: ESR 13 mm/h, CRP \ 3.0 mg/l, ANA(-), anti-
ENA(-), RF(-) and anti-CCP(-). His liver, kidneys and
growth hormone tests were within normal ranges. The
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X-ray of his bones revealed irregular periosteal hypertro-
phy with bone formation affecting his long bones and
phalanges bilaterally (Fig. 2). There was no abnormal
finding on his chest radiograph, abdominal ultrasound,
echocardiograph and gastroendoscopy examinations. The
synovial fluid obtained from his knee was non-inflamma-
tory. On gross examination, the synovial biopsy sample
from his right knee showed venous dilatation, and histo-
logical examination demonstrated endothelial hyperplasia
and vascular thickening without any inflammation (Fig. 3).
Immunohistochemical staining revealed that the proportion
of CD200? and CD200R1? cells were down-regulated
compared with that from healthy control and a PHO patient
without synovium hyperplasia. In addition, not like the
CD200? cells in the PHO without synovium hyperplasia,
which was mainly identified in the lining layer and to a
lesser extent in the sublining layer, the CD200? cells in the
PHO patient with hyperplastic synovium extended to the
vascular endothelial regions, whereas CD200R1? cells
were hardly detected (Fig. 4).
Discussion
PHO, or touraine-solente-gole syndrome (TSG), which is
often familial and affects predominantly male, was firstly
reported by Friedrich in 1868 [2]. It can be divided into
primary and secondary subtypes. The case presented here is
a complete form of pachydermoperiostosis (PDP), the
primary form of PHO, since he had hyperostosis, finger
clubbing and pachydermia without any underlying cardio-
vascular, pulmonary, liver, intestinal or mediastinal dis-
eases. Importantly, PDP with refractory and painful
synovium hyperplasia, as demonstrated in our patient, is
rarely reported. As the synovial fluid in this case is non-
inflammatory, we need to explore why he had painful
synovial hyperplasia. Thereby, we performed synovial
biopsy on his right knee and found venous dilatation. The
histological examination demonstrated endothelial hyper-
plasia and vascular thickening in his synovium compared
with that from healthy and PHO control, highlighting the
pathology of vascular neoformation and microangiopathy
in the hyperplastic synovium of this PHO case.
CD200 is a type I transmembrane glycoprotein belong-
ing to the immunoglobulin superfamily, is widely distrib-
uted in various tissues including the vascular endothelium
[3], is known for its immunoregulatory function in immune
response [4–6] and may participate in the regulation of the
endothelial function [7]. In our previous study, we dem-
onstrated that there was an abnormal expression of CD200
and CD200R1 in RA patients and this abnormality con-
tributes to the immunopathogenesis of RA. However, our
knowledge of the role of the CD200/CD200R1 axis in
human PHO is limited. Given that apparent painful syno-
vial hyperplasia existed either in RA or this PHO case, it
would be very interesting to explore whether this pathway





Fig. 1 Clinical findings of the PHO patient with hyperplastic
synovium. a Furrowy forehead; b clubbing fingers; c bilateral knee
effusion; d ankles with oedema
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Fig. 2 Radiography of the PHO patient with hyperplastic synovium.
a Normal X-ray; b both hands showed periostosis; c both legs showed
periostitis in the proximal tibia; d pronounced periosteal reaction at
the distal end of femur (arrow)
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inflammatory disease, especially in PHO. We therefore
assessed the distribution and extent of CD200 in the syn-
ovium of this PHO case, and we found that there were less
CD200? and CD200R1? cells in his synovium compared
to HC and the PHO patient without synovium hyperplasia.
Of note, not like the CD200? cells in the PHO patient
without synovium hyperplasia, which was mainly identi-
fied in the lining layer and to a lesser extent in the sublining
layer, the CD200? cells in this PHO patient with hyper-
plastic synovium extended to the vascular endothelial
regions, whereas CD200R1? cells were hardly detected.
The explanation for this discrepancy is not certain, but the
refractory synovial effusion observed in this PHO was
associated with aberrant local expression of CD200/
CD200R1 that might led to abnormal vascular
neoformation and microangiopathy since the following
ultrastructural examination verified increased activation of
endothelial cells at the sites of capillaries and arteriovenous
anastomoses of this PHO case, highlighting the importance
of CD200-CD200R1 interaction in the regulation of the
endothelial activation, which might result in increased
susceptibility to perivascular lymphocytic infiltrate, and
ultimately lead to fluid effusion. Furthermore, availabilities
of endothelial CD200 and CD200R1 in the blood vessels
may contribute to the unequal predisposition of patholog-
ical conditions such as enhanced vascular dysfunction and
alterative permeability.
In summary, we reported a case of PHO with synovium
hyperplasia which was refractory to treatment and high-
lighted the importance of aberrant CD200/CD200R1 in the
CBA
Fig. 3 Synovium histology. This PHO patient with hyperplastic
synovium had endothelial hyperplasia and vascular thickening
(arrow) without inflammation (Haematoxylin and eosin staining,
original magnification 9 200). The histology of the synovium from a
healthy control (HC) and a PHO patient without hypertrophic





Fig. 4 Immunohistochemistry examination of the PHO patient with
hyperplastic synovium demonstrated less expression of CD200
(b) and CD200R1 (e) in the synovium of the PHO with hypertrophic
synovium compared with that of healthy control (HC, a, d) and a
PHO patient without synovium hyperplasia (c, f, original
magnification 9 200)
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regulation of the endothelial activation that contribute to
the development of synovium hyperplasia.
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